array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Thu, 19 Dec 2024 17:11:58 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6ImNuVEtld29HM1VncUJ5blljV1BML3c9PSIsInZhbHVlIjoiWUV6TTF0dUhXY0dBTGJmMHhPalZBQTRUTXRTa2hMMVVIQ0xpamVKY0s1aU4yT1k5anYwdDYrRWFQa2FITzJLNTVzVkZDT0VTTnRiajMza2s4U01vdmJFVHNuM0ZOQitPbFpoR0xNcm9iSVUrSVA5MzR5VVhudThWbWNxMHlSQjMiLCJtYWMiOiJlMzU3NjhkNWU1ZWJlYTllNGYyMTVlNjkxYjVlNGQyNWJhNDdhMTZiODdlZDcwMGY2YmViMjk5NmE2ZGQxMzNlIiwidGFnIjoiIn0%3D; expires=Sun, 22 Dec 2024 05:11:58 GMT; Max-Age=216000; path=/; secure; samesite=strict"
    1 => "eurekaselectnew_session=eyJpdiI6IjVUakpoNVVJNC94d3gwdWpaeng0SWc9PSIsInZhbHVlIjoiUWM5dE0rMndPTi9zNWV0Q1pkckc1Y2xXd0dFd1ZTOU9JYktaQU5KeU5lbDB4NlNVVTRtWjArdFdXZVlzMWdJcERReTllU3Zhc3RzdEtQdUxKR0l3NWZGOGZvZW4vMUl3STVsMEpsOFA4Q3BVWTB1WnRYc1dRTkxZV21TOHMwckoiLCJtYWMiOiIwOThmYzliZjU3Y2MxMmVmYTM0NGEyOGY2NDY2MTQ2YzQzZjkxYzA3NWQ5NTBhNDkxNGU2ZjBjOTE2NTc0MTY1IiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=strict"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6ImNuVEtld29HM1VncUJ5blljV1BML3c9PSIsInZhbHVlIjoiWUV6TTF0dUhXY0dBTGJmMHhPalZBQTRUTXRTa2hMMVVIQ0xpamVKY0s1aU4yT1k5anYwdDYrRWFQa2FITzJLNTVzVkZDT0VTTnRiajMza2s4U01vdmJFVHNuM0ZOQitPbFpoR0xNcm9iSVUrSVA5MzR5VVhudThWbWNxMHlSQjMiLCJtYWMiOiJlMzU3NjhkNWU1ZWJlYTllNGYyMTVlNjkxYjVlNGQyNWJhNDdhMTZiODdlZDcwMGY2YmViMjk5NmE2ZGQxMzNlIiwidGFnIjoiIn0%3D; expires=Sun, 22-Dec-2024 05:11:58 GMT; path=/; secure"
    1 => "eurekaselectnew_session=eyJpdiI6IjVUakpoNVVJNC94d3gwdWpaeng0SWc9PSIsInZhbHVlIjoiUWM5dE0rMndPTi9zNWV0Q1pkckc1Y2xXd0dFd1ZTOU9JYktaQU5KeU5lbDB4NlNVVTRtWjArdFdXZVlzMWdJcERReTllU3Zhc3RzdEtQdUxKR0l3NWZGOGZvZW4vMUl3STVsMEpsOFA4Q3BVWTB1WnRYc1dRTkxZV21TOHMwckoiLCJtYWMiOiIwOThmYzliZjU3Y2MxMmVmYTM0NGEyOGY2NDY2MTQ2YzQzZjkxYzA3NWQ5NTBhNDkxNGU2ZjBjOTE2NTc0MTY1IiwidGFnIjoiIn0%3D; path=/; secure; httponly"
  ]
]

Search Result "BETd-246"

The Klf6 Super-enhancer Determines Klf6 Sensitivity to BRD4 Inhibitors in Human Hepatoma (HepG2) Cells

Recent Advances in the Design and Development of Anticancer Molecules based on PROTAC Technology

Apply Filters

Content Type